Correlation Between Regeneron Pharmaceuticals and Cimpress
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Cimpress at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Cimpress into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Cimpress NV, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Cimpress and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Cimpress. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Cimpress.
Diversification Opportunities for Regeneron Pharmaceuticals and Cimpress
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Regeneron and Cimpress is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Cimpress NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cimpress NV and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Cimpress. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cimpress NV has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Cimpress go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and Cimpress
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Cimpress. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 1.25 times less risky than Cimpress. The stock trades about -0.15 of its potential returns per unit of risk. The Cimpress NV is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest 7,039 in Cimpress NV on November 4, 2024 and sell it today you would lose (391.00) from holding Cimpress NV or give up 5.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Regeneron Pharmaceuticals vs. Cimpress NV
Performance |
| Timeline |
| Regeneron Pharmaceuticals |
| Cimpress NV |
Regeneron Pharmaceuticals and Cimpress Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Regeneron Pharmaceuticals and Cimpress
The main advantage of trading using opposite Regeneron Pharmaceuticals and Cimpress positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Cimpress can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cimpress will offset losses from the drop in Cimpress' long position.| Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
| Cimpress vs. Innovid Corp | Cimpress vs. Deluxe | Cimpress vs. Omnicom Group | Cimpress vs. Emerald Expositions Events |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |